The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

VEOZAH is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. VEOZAH is not a ...

The Food and Drug Administration (FDA) just approved a brand-new, once-a-day pill to help treat hot flashes without the use of hormones. The drug, called elinzanetant—brand name Lynkuet—was created by ...

The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

(CNN) — The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

Oct 24 (Reuters) - The U.S. Food and Drug Administration has approved Bayer's (BAYGn.DE), opens new tab drug to ease hot flashes in menopausal women, the German company said on Friday, a welcome ...

Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. The Food and Drug Administration approved the drug — also known by ...

Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help with sleep issues. By Nina Agrawal and Maggie Astor The Food and Drug ...